Iovance Biotherapeutics, Inc.
DE ˙ DB ˙ US4622601007
3,31 € ↓ -0,17 (-4,89%)
2026-06-04
DEL PRIS
SecurityDE:2LB / Iovance Biotherapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership9,414,292 shares
Latest Disclosed Value $ 33,044,165
Millennium Management Llc ownership in 2LB / Iovance Biotherapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 9,414,292 shares of Iovance Biotherapeutics, Inc. (DE:2LB) valued at $27,004,897 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 6,585,532 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 42.95% during the quarter. The current value of the position is $31,161,307 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (2LB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:2LB / Iovance Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,414,292 2,828,760 42.95 33,044 83.80 0.0138
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 6,585,532 2,172,081 49.22 17,979 87.72 0.0076
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 4,413,451 -4,916,772 -52.70 9,577 -40.32 0.0041
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,330,223 9,171,900 5,793.16 16,048 2,944.97 0.0077
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 158,323 82,829 109.72 527 -5.56 0.0003
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 75,494 -75,445 -49.98 559 -60.62 0.0003
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 150,939 -15,210 -9.15 1,417 6.38 0.0007
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 166,149 -1,450,712 -89.72 1,333 -94.44 0.0006
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,616,861 677,315 72.09 23,962 213.71 0.0102
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 939,546 -6,880,528 -87.99 7,639 -78.53 0.0033
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 7,820,074 4,239,406 118.40 35,581 41.16 0.0180
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 3,580,668 168,069 4.92 25,208 20.89 0.0124
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 3,412,599 2,229,060 188.34 20,851 175.70 0.0120
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,183,539 -37,426 -3.07 7,563 -35.34 0.0042
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,220,965 -190,222 -13.48 11,697 -24.92 0.0069
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,411,187 -961,220 -40.52 15,580 -60.56 0.0097
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,372,407 2,042,116 618.28 39,501 526.50 0.0209
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 330,291 330,291 6,305 0.0032
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -580,977 -100.00 0 -100.00
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 580,977 403,549 227.44 18,394 123.42 0.0132
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 177,428 -634,217 -78.14 8,233 -69.19 0.0059
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 811,645 224,136 38.15 26,719 65.68 0.0329
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 587,509 429,579 272.01 16,127 241.10 0.0221
2020-05-14 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 157,930 157,930 4,728 0.0106
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -406,526 -100.00 0 -100.00
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 406,526 283,007 229.12 7,398 33.90 0.0117
2019-08-14 2019-06-30 13F HEARTLAND FINL USA COM 462260100 123,519 105,112 571.04 5,525 3,057.14 0.0083
2019-05-14 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 18,407 18,407 175 0.0003
2019-02-15 2018-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 0 -60,387 -100.00 0 -100.00
2018-11-14 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 60,387 -652,535 -91.53 679 -92.56 0.0008
2018-08-14 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 712,922 202,558 39.69 9,125 5.80 0.0119
2018-05-15 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 510,364 -139,287 -21.44 8,625 65.96 0.0115
2018-02-14 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 649,651 -1,431,829 -68.79 5,197 -67.78 0.0072
2017-11-14 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,081,480 1,652,045 384.70 16,131 411.12 0.0246
2017-08-14 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 429,435 416,435 3,203.35 3,156 3,153.61 0.0056
2017-05-15 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 13,000 -81,828 -86.29 97 -85.28 0.0002
2017-02-14 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 94,828 94,828 0.00 659 0.0014
2016-11-14 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 0 -154,631 -100.00 0 -100.00
2016-08-15 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 154,631 117,838 320.27 1,253 570.05 0.0029
2016-05-16 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 36,793 6,197 20.25 187 -20.76 0.0005
2016-02-16 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 30,596 30,596 0.00 236 0.0005
2015-11-16 2015-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 0 -13,152 -100.00 0 -100.00
2015-08-14 2015-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 13,152 -14,958 -53.21 121 -64.41 0.0002
2015-05-15 2015-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 28,110 28,110 340 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 235,500 643 n/a n/a n/a
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 100,000 333 n/a n/a n/a
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 50,000 401 n/a n/a n/a
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 51,900 -3.35 422 72.54 n/a n/a n/a
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 53,700 244 n/a n/a n/a
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 321,800 197.69 3,553 97.39 n/a n/a n/a
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 108,100 1,800 n/a n/a n/a
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 20,000 -85.71 520 -88.27 n/a n/a n/a
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 140,000 55.56 4,432 6.13 n/a n/a n/a
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 90,000 -18.18 4,176 15.33 n/a n/a n/a
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 110,000 3,621 n/a n/a n/a
2020-05-14 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 184,400 5,104 n/a n/a n/a
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-15 2019-06-30 13F/A IOVANCE BIOTHERAPEUTICS COM Call 139,500 3,421 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 165,000 450 n/a n/a n/a
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 103,700 472 n/a n/a n/a
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 303,100 3,346 n/a n/a n/a
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 10,000 317 n/a n/a n/a
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-14 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 10,000 299 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.